113 related articles for article (PubMed ID: 8555051)
21. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
Schwartzberg LS; Birch R; Hazelton B; Tauer KW; Lee P; Altemose R; George C; Blanco R; Wittlin F; Cohen J
J Hematother; 1992; 1(4):317-27. PubMed ID: 1285381
[TBL] [Abstract][Full Text] [Related]
22. Combination of stem cell factor and granulocyte colony-stimulating factor mobilizes the highest number of primitive haemopoietic progenitors as shown by pre-colony-forming unit (pre-CFU) assay.
Horsfall MJ; Hui CH; To LB; Begley CG; Basser RL; Simmons PJ
Br J Haematol; 2000 Jun; 109(4):751-8. PubMed ID: 10929025
[TBL] [Abstract][Full Text] [Related]
23. Primitive hematopoietic progenitor cells are present in peripheral blood autografts.
Tong J; Gianni AM; Siena S; Srour EF; Bregni M; Hoffman R
Blood Cells; 1994; 20(2-3):351-62; discussion 362-3. PubMed ID: 7538339
[TBL] [Abstract][Full Text] [Related]
24. Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.
Motta MR; Mangianti S; Rizzi S; Ratta M; Campanini E; Fortuna A; Fogli M; Tura S; Lemoli RM
Exp Hematol; 1997 Nov; 25(12):1261-9. PubMed ID: 9357970
[TBL] [Abstract][Full Text] [Related]
25. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
[TBL] [Abstract][Full Text] [Related]
26. Early suppressive effects of chemotherapy and cytokine treatment on committed versus primitive haemopoietic progenitors in patient bone marrow.
Schwartz GN; Hakim F; Zujewski J; Szabo JM; Cepada R; Riseberg D; Warren MK; Mackall CL; Setzer A; Noone M; Cowan KH; O'Shaughnessy J; Gress RE
Br J Haematol; 1996 Mar; 92(3):537-47. PubMed ID: 8616014
[TBL] [Abstract][Full Text] [Related]
27. CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF.
Cesana C; Carlo-Stella C; Regazzi E; Garau D; Sammarelli G; Caramatti C; Tabilio A; Mangoni L; Rizzoli V
Bone Marrow Transplant; 1998 Mar; 21(6):561-8. PubMed ID: 9543059
[TBL] [Abstract][Full Text] [Related]
28. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
[TBL] [Abstract][Full Text] [Related]
29. In vitro expansion of CD34+ cells mobilized with chemotherapy and G-CSF.
Teofili L; Iovino MS; Di Mario A; Ortu La Barbera E; Pierelli L; Bussa S; Rumi C; Menichella G; Leone G
Int J Artif Organs; 1993 Dec; 16 Suppl 5():89-95. PubMed ID: 7516922
[TBL] [Abstract][Full Text] [Related]
30. [Mobilization of circulating hematopoietic stem cells by granulocyte colony stimulating factor after chemotherapy in multiple myeloma].
Ohler L; Scholten C; Reiter E; Tiefengraber E; Jäger U; Strobl H; Lechner K; Höcker P; Geissler K
Wien Klin Wochenschr; 1993; 105(20):580-4. PubMed ID: 7505076
[TBL] [Abstract][Full Text] [Related]
31. [Kinetics of circulating hematopoietic stem cells following chemotherapy in patients with hematopoietic malignancies].
Tamura K; Kosaka M; Mizuguchi T; Miyamoto Y
Rinsho Ketsueki; 1990 May; 31(5):647-54. PubMed ID: 1697629
[TBL] [Abstract][Full Text] [Related]
32. Kinetics of circulating haematopoietic progenitors during chemotherapy-induced mobilization with or without granulocyte colony-stimulating factor.
Liu KY; Akashi K; Harada M; Takamatsu Y; Niho Y
Br J Haematol; 1993 May; 84(1):31-8. PubMed ID: 7687859
[TBL] [Abstract][Full Text] [Related]
33. Harvest quality and factors affecting collection and engraftment of CD34+ cells in patients with breast cancer scheduled for high-dose chemotherapy and peripheral blood progenitor cell support.
Papadopoulos KP; Ayello J; Tugulea S; Heitjan DF; Williams C; Reiss RF; Vahdat LT; Suciu-Foca N; Antman KH; Hesdorffer CS
J Hematother; 1997 Feb; 6(1):61-8. PubMed ID: 9112219
[TBL] [Abstract][Full Text] [Related]
34. Spontaneous and granulocyte–colony-stimulating factor-enhanced marrow response and progenitor cell mobilization in mice after myocardial infarction.
Delgaudine M; Gothot A; Beguin Y
Cytotherapy; 2010 Nov; 12(7):909-18. PubMed ID: 20230223
[TBL] [Abstract][Full Text] [Related]
35. Effects of in vivo treatment with PIXY321 (GM-CSF/IL-3 fusion protein) on proliferation kinetics of bone marrow and blood myeloid progenitor cells in patients with sarcoma.
Broxmeyer HE; Benninger L; Cooper S; Hague N; Benjamin RS; Vadhan-Raj S
Exp Hematol; 1995 Apr; 23(4):335-40. PubMed ID: 7895781
[TBL] [Abstract][Full Text] [Related]
36. Comparison of megakaryopoiesis in vitro of paired peripheral blood progenitor cells and bone marrow harvested during remission in patients with acute myeloid leukaemia.
Briggs M; Adams JA; Brereton ML; Burgess R; Hyde K; Lenehan H; Yin JA
Br J Haematol; 2001 Dec; 115(3):563-8. PubMed ID: 11736936
[TBL] [Abstract][Full Text] [Related]
37. Transplantation potential of peripheral whole blood primed by VACOP-B chemotherapy plus filgrastim (r-metHuG-CSF) in patients with aggressive non-Hodgkin's lumphoma.
Corato A; Ambrosetti A; Rossi B; Vincenzi C; Lambiase A; Perona G; Pizzolo G; de Wynter E; Nadali G
J Hematother Stem Cell Res; 2000 Oct; 9(5):673-82. PubMed ID: 11091491
[TBL] [Abstract][Full Text] [Related]
38. Mobilization of peripheral blood progenitor cells following CHOP treatment combined with delayed granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma.
Takano H; Sawada K; Sato N; Natoya A; Tarumi T; Hirayama S; Koizumi K; Takahashi TA; Sekiguchi S; Koike T
Leuk Lymphoma; 1996 May; 21(5-6):473-8. PubMed ID: 9172813
[TBL] [Abstract][Full Text] [Related]
39. Selection and characterization of early hematopoietic progenitors using an anti-CD71/S06 immunotoxin.
Benedetti G; Bondesan P; Caracciolo D; Cherasco C; Ruggieri D; Gastaldi ME; Pileri A; Gianni AM; Tarella C
Exp Hematol; 1994 Feb; 22(2):166-73. PubMed ID: 7507858
[TBL] [Abstract][Full Text] [Related]
40. Effects of granulocyte-colony-stimulating factor on progenitor cell mobilization and heart perfusion and function in normal mice.
Delgaudine M; Lambermont B; Lancellotti P; Roelants V; Walrand S; Vanoverschelde JL; Pierard L; Gothot A; Beguin Y
Cytotherapy; 2011 Feb; 13(2):237-47. PubMed ID: 20524771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
